The neuroprotective effects of melatonin against diabetic neuropathy: A systematic review of non-clinical studies

Backgrounds: Diabetes can cause diabetic neuropathy (DN), a nerve injury. High blood sugar (glucose) levels can harm nerves all over your body. The nerves in your legs and feet are the most commonly affected by DN. The purpose of this study was to conduct a review of melatonin's potential neuro...

Full description

Saved in:
Bibliographic Details
Main Authors: Asieh Hosseini (Author), Mahedeh Samadi (Author), Maryam Baeeri (Author), Mahban Rahimifard (Author), Hamed Haghi-Aminjan (Author)
Format: Book
Published: Frontiers Media S.A., 2022-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_ba9259b6266f4881bc74c01d2f357a6c
042 |a dc 
100 1 0 |a Asieh Hosseini  |e author 
700 1 0 |a Mahedeh Samadi  |e author 
700 1 0 |a Maryam Baeeri  |e author 
700 1 0 |a Mahban Rahimifard  |e author 
700 1 0 |a Hamed Haghi-Aminjan  |e author 
245 0 0 |a The neuroprotective effects of melatonin against diabetic neuropathy: A systematic review of non-clinical studies 
260 |b Frontiers Media S.A.,   |c 2022-08-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2022.984499 
520 |a Backgrounds: Diabetes can cause diabetic neuropathy (DN), a nerve injury. High blood sugar (glucose) levels can harm nerves all over your body. The nerves in your legs and feet are the most commonly affected by DN. The purpose of this study was to conduct a review of melatonin's potential neuroprotective properties against DN.Method: A full systematic search was conducted in several electronic databases (Scopus, PubMed, and Web of Science) up to March 2022 under the PRISMA guidelines. Forty-seven studies were screened using predefined inclusion and exclusion criteria. Finally, the current systematic review included nine publications that met the inclusion criteria.Result: According to in vivo findings, melatonin treatment reduces DN via inhibition of oxidative stress and inflammatory pathways. However, compared to the diabetes groups alone, melatonin treatment exhibited an anti-oxidant trend. According to other research, DN also significantly produces biochemical alterations in neuron cells/tissues. Additionally, histological alterations in neuron tissue following DN were detected.Conclusion: Nonetheless, in the majority of cases, these diabetes-induced biochemical and histological alterations were reversed when melatonin was administered. It is worth noting that the administration of melatonin ameliorates the neuropathy caused by diabetes. Melatonin exerts these neuroprotective effects via various anti-oxidant, anti-inflammatory, and other mechanisms. 
546 |a EN 
690 |a diabetic neuropathy 
690 |a melatonin 
690 |a oxidative stress 
690 |a inflammation 
690 |a systemic review 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 13 (2022) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fphar.2022.984499/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/ba9259b6266f4881bc74c01d2f357a6c  |z Connect to this object online.